PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Potential Financial Implications of Yesterday's Results, page-72

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Should be able to approximate costs by looking at Elmiron. Margins are going to be massive. If DMOAD is proven, I can't see royalties being any less than 65%.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.